Polarean Imaging enters contract with University of British Columbia
15th Feb 2019 10:27
(Sharecast News) - Medical imaging technology company Polarean Imaging has entered into a contract for the procurement of its latest polariser system by the University of British Columbia, it announced on Friday, following the conclusion of UBC's procurement process.
Read moreTuesday broker round-up
11th Dec 2018 13:41
(Sharecast News) - ASOS: Morgan Stanley downgrades to underweight with a target price of 3,200p.
Read morePolarean Imaging progresses to Phase III trial of hyperpolarised 129-Xenon
23rd Aug 2018 14:53
(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Thursday that the first patient has been enrolled in its Phase III FDA clinical trial, which aims to demonstrate non-inferiority of its drug-device combination using hyperpolarised 129-Xenon (129Xe) gas MRI, against an approved comparator.
Read morePolarean upbeat on results of pilot study
27th Jul 2018 09:26
(Sharecast News) - Medical imaging technology company Polarean Imaging announced the allowance of the latest patents on polarisation, the results of a 'pilot study' that was undertaken in preparation for its upcoming phase III clinical trials, and an update regarding phase III trials on Friday.
Read more